NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

FBTvsPBEETF Comparison

ETF 1
FBT

First Trust NYSE Arca Biotechnology Index Fund ETF

This fund is part of
US Health Care
-0%
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-0.39%

First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. FBT is less expensive with a Total Expense Ratio (TER) of 0.54%, versus 0.58% for PBE. FBT is up 10.4% year-to-date (YTD) with +$1.12B in YTD flows. PBE performs worse with 2.54% YTD performance, and -$3M in YTD flows. Run a side-by-side ETF comparison of FBT and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FBT vs PBE performance and flow charts

Performance

-2.00.02.04.06.08.0%May 11May 18May 26Jun 2Jun 9

Cumulative Flows

0 M10 M20 M30 M40 M50 M60 MMay 11May 18May 26Jun 2Jun 9

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 06/11/2026
1M3MYTD1Y3Y5Y
Perf.
FBT
PBE
+8.63%+1.33%
+14.03%+10.39%
+10.40%+2.54%
+38.20%+31.31%
+44.56%+34.96%
+30.74%+10.44%
Flows
FBT
PBE
+$31M+$2M
+$23M-$3M
+$1.12B-$3M
+$1.16B-$26M
+$677M-$56M
+$382M-$45M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FBT
PBE
+24.91%+19.82%
+21.21%+19.09%
+20.51%+20.14%
+22.00%+22.41%
Max drawdown
FBT
PBE
-4.56%-4.08%
-14.27%-11.70%
-19.92%-22.21%
-29.91%-34.74%
Max drawdown duration
FBT
PBE
19d16d
126d156d
237d324d
1159d1540d
Trading data

Create an account to view trading data

Join for free
FBT
PBE
Last sale
6/15/2026 at 1:30 PM
$227.33
$84.64
Previous close
06/12/2026
$225.61
$84.10
Consolidated volume
06/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of May 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FBT
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 6/15/2026 at 1:30 PM
Live
Closed
FBT
PBE
Last price
$227.33
$84.64
1D performance
+0.76%
+0.64%
AuM$2.63 B$259.85 M
E/R0.54%0.58%
Characteristics
FBT
PBE
Management strategyPassivePassive
ProviderFirst TrustInvesco
BenchmarkNYSE Arca Biotechnology IndexDynamic Biotech & Genome Intellidex Index
N° of holdings2730
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 19, 2006June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

FBT
USA
90.25%
Other
9.75%
PBE
USA
92.2%
Other
7.8%

Sectors

FBT
Health Care
87.26%
Other
12.74%
PBE
Health Care
97.78%
Other
2.22%
Advertisement

Diversification

FBT

Total weight of top 15 holdings out of 15

52.3%
PBE

Total weight of top 15 holdings out of 15

62.95%

Top 15 holdings

Data as of April 30, 2026
FBT
NEOGENOMICS
3.86%
ADMA BIOLOGICS INC
3.69%
CORCEPT THERAPEUTICS
3.66%
ARROWHEAD PHARMACEUTICALS INC
3.54%
VERACYTE INC/D
3.54%
BIONTECH SE ADR
3.51%
BIOGEN INC
3.49%
ILLUMINA
3.45%
KRYSTAL BIOTECH INC
3.42%
AXSOME THERA CMN STK
3.42%
NATERA
3.41%
ALKERMES
3.36%
INCYTE
3.35%
EXELIXIS
3.34%
UTD THERAPEUT
3.27%
PBE
UTD THERAPEUT
6.20%
ILLUMINA
5.42%
REGENERON PHARMACEUTICALS
4.99%
INCYTE
4.91%
ALNYLAM PHARMACEUTICALS
4.80%
BIOGEN INC
4.80%
AMGEN-T
4.60%
GILEAD SCIENCES
4.48%
CATALYST PHARMACEUTICALS INC
3.42%
BIOCRYST PHARMACEUTICALS
3.30%
TG THERAPEUTICS
3.28%
ARROWHEAD PHARMACEUTICALS INC
3.27%
CAREDX INC/D
3.21%
PROTAGONIST THERAPEUTICS INC
3.18%
ROYALTY PHARMA
3.09%
Frequently asked questions about FBT and PBE

How have the FBT and PBE ETFs performed in 2026?

As of June 11, 2026, FBT is up 10.4% year-to-date (YTD), while PBE has returned 2.54%. That puts FBT better performer ahead so far this year.

Which ETF is attracting more investor money: FBT or PBE?

Year-to-date, the FBT ETF saw +$1.12B in flows, compared to -$3M for PBE.

Which ETF is more volatile: FBT or PBE?

Over the past year, FBT had a volatility of 21.21%, while PBE experienced 19.09%.

Which ETF is bigger: FBT or PBE?

As of June 11, 2026, FBT holds $2.63 B in assets under management (AUM), while PBE manages $259.85 M.

What sectors do the FBT and PBE ETFs invest in?

FBT leans toward sectors like Health Care. Meanwhile, PBE focuses on Health Care.

What are the top holdings of the FBT ETF and PBE ETF?

FBT top holdings include NEOGENOMICS, ADMA BIOLOGICS INC and CORCEPT THERAPEUTICS. PBE holds in its top three: UTD THERAPEUT, ILLUMINA and REGENERON PHARMACEUTICALS.

Which ETF is more diversified: FBT or PBE?

FBT holds 28 securities with 52.3% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 62.95%.

Advertisement
Latest news about FBT & PBE
Advertisement
Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.